CareLit · DOI-Nachweis · Pneumologie
Safety, tolerability and clinical effects of a rapid dose titration of subcutaneous treprostinil therapy in pulmonary arterial hypertension: a prospective multi-centre trial.
DOI 10.1055/s-0036-1572125
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB Egenlauf, E Grünig, N Benjamin, TJ Lange, U Krüger, HF Klose, C Neurohr, H Wilkens, M Halank, HJ Seyfarth, M Held, A Traube, M Pernow, RE Grover, F Gerhardt, T Viethen, S Rosenkranz
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: The objective of this open label, multi-centre study was to evaluate safety, tolerability and clinical effects of a rapid up-titration dosing regimen of subcutaneous (SC) treprostinil using pro-active infusion site pain management in patients with severe pulmonary arterial hypertension (PAH). Methods: Safety and tolerability were assessed by adverse events and discontinuation rate. Clinical parameters an…
Zitieren
Zitierempfehlung
B Egenlauf, E Grünig, N Benjamin, TJ Lange, U Krüger, HF Klose, C Neurohr, H Wilkens, M Halank, HJ Seyfarth, M Held, A Traube, M Pernow, RE Grover, F Gerhardt, T Viethen, S Rosenkranz (2016) Safety, tolerability and clinical effects of a rapid dose titration of subcutaneous treprostinil therapy in pulmonary arterial hypertension: a prospective multi-centre trial. Pneumologie (02). https://doi.org/10.1055/s-0036-1572125
Mit CareLit weiterarbeiten